• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

March 20, 2017

Trending News Today: Cost of Hepatitis C Drugs Still Under Scrutiny

Author(s):

Lauren Santye, Assistant Editor

Top news of the day from across the health care landscape.

The score of a common blood test may one day be able to predict a patient’s risk of developing a chronic disease within 3 years of taking the test, according to NPR. The Intermountain Chronic Disease Risk Score is based on the results of a comprehensive metabolic panel that includes tests for blood glucose, liver function, and a complete blood count. The risk score was 77% to 78% accurate in predicting whether an individual would be diagnosed with diseases such as diabetes, kidney failure, coronary artery disease, and dementia. The test used in the score is commonly performed at checkups, and the score can be calculated by a hospital’s electronic health record. The study’s principal investigator, Heidi May, hopes the score could eventually help physicians better allocate their time and resources, NPR reported.

Since blockbuster hepatitis C virus (HCV) drugs have come onto the market, manufacturers have received criticism over the high price tags. Meanwhile, health insurers and state Medicaid programs have been coming up with ways to limit access to these lifesaving drugs, according to NPR. Dr Peter Bach, director of health policy and outcomes at Memorial Sloan Kettering Cancer Center, proposes a solution to address the issue: buying up the company, specifically Gilead Sciences. Dr Bach said if the federal government bought Gilead, it could save money and treat everyone in the United States with HCV. Since the launch of Sovaldi and Harvoni, approximately 600,000 patients have been treated, a figure that is low considering the availability of a cure, NPR reported.

Researchers and advocates are speaking out against President Donald Trump’s proposed federal budget, saying it would be a devastating blow to cancer research. According to The Washington Post, critics say the 19% cut for the National Institutes of Health could cripple or kill former Vice President Joe Biden’s cancer moonshot initiative, as well as other important biomedical efforts. “Forget about the moonshot. What about everything on the ground?” George Demetri, an oncologist at Dana-Farber Cancer Institute in Boston, told the Post. “Fundamentally, this is so extreme that all I can think is that it’s pushing 2 orders of magnitude off the grid so that when people come back to less extreme positions it looks normal.”

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue
Image credit: Dr_Microbe | stock.adobe.com
Related Content
Advertisement
Woman doctor nutritionist hands in white shirt with omega 3, vitamin D capsules with green vegan food. The doctor prescribes a prescription for medicines and vitamins at clinic  - Image credit: Galina Zhigalova | stock.adobe.com
June 13th 2025

Study Shows High-Dose Vitamin D Boosts Treatment Response in Breast Cancer

Kennedy Ferruggia, Assistant Editor
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
Gloved hand holding blood test sample | Image Credit: © StudioLaMagica - stock.adobe.com
June 13th 2025

Blood Test Outperforms Tissue Biopsy in Detecting HPV+ Head and Neck Cancer

Alexandra Gerlach, Associate Editor
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
Molecular model of pembrolizumab | Image Credit: © Dr_Microbe - stock.adobe.com
June 12th 2025

Pembrolizumab Receives FDA Approval for Treatment of Head and Neck Squamous Cell Carcinoma

Alexandra Gerlach, Associate Editor
raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com
June 12th 2025

Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers

Kennedy Ferruggia, Assistant Editor
Related Content
Advertisement
Woman doctor nutritionist hands in white shirt with omega 3, vitamin D capsules with green vegan food. The doctor prescribes a prescription for medicines and vitamins at clinic  - Image credit: Galina Zhigalova | stock.adobe.com
June 13th 2025

Study Shows High-Dose Vitamin D Boosts Treatment Response in Breast Cancer

Kennedy Ferruggia, Assistant Editor
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
Gloved hand holding blood test sample | Image Credit: © StudioLaMagica - stock.adobe.com
June 13th 2025

Blood Test Outperforms Tissue Biopsy in Detecting HPV+ Head and Neck Cancer

Alexandra Gerlach, Associate Editor
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
Molecular model of pembrolizumab | Image Credit: © Dr_Microbe - stock.adobe.com
June 12th 2025

Pembrolizumab Receives FDA Approval for Treatment of Head and Neck Squamous Cell Carcinoma

Alexandra Gerlach, Associate Editor
raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com
June 12th 2025

Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers

Kennedy Ferruggia, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.